NeoGenomics Inc (NEO)

Add to Watchlists
Create an Alert
Quickflows
36.62 -1.26  -3.33% NASDAQ May 13, 16:59 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All NEO News

News

View All Events

Events

Date Type Description
07/28/2021 00:00 Earnings Results Q2 2021 Earnings Results
07/28/2021 08:30 Earnings Calls Q2 2021 Earnings Call
05/05/2021 00:00 Earnings Results Q1 2021 Earnings Results
05/05/2021 08:30 EDT Earnings Calls Q1 2021 Earnings Call
02/24/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/24/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
10/27/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/27/2020 08:30 EDT Earnings Calls Q3 2020 Earnings Call
07/28/2020 08:30 EDT Earnings Calls Q2 2020 Earnings Call
07/28/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 453.95M
Total Expenses (TTM) 477.76M
Net Income (TTM) -10.96M

Balance Sheet View Statement

Total Assets (Quarterly) 1.494B
Total Liabilities (Quarterly) 650.70M
Shareholders Equity (Quarterly) 843.71M

Cash Flow Statement View Statement

Cash from Operations (TTM) 10.60M
Cash from Investing (TTM) -272.42M
Cash from Financing (TTM) 759.92M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
  • URL: https://www.neogenomics.com
  • Investor Relations URL: https://ir.neogenomics.com/
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Jul. 28, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 36.62
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
PSCH Invesco S&P SmallCap Health Care ETF 4.06%
ARTSX Artisan Small Cap Investor 3.63%
EDOC Global X Telemedicine & Digital Hlth ETF 3.47%
ASYMX Alger Weatherbie Specialized Growth Y 2.57%
BASAX Brown Advisory Small-Cap Growth Adv 2.14%
FSSRX Franklin Small Cap Growth R 1.19%
JVTCX Janus Henderson Venture C 1.11%
SLYG SPDR® S&P 600 Small Cap Growth ETF 0.96%
IJT iShares S&P Small-Cap 600 Growth ETF 0.94%
VIOO Vanguard S&P Small-Cap 600 ETF 0.55%
VTSIX Vanguard Tax-Managed Small Cap I 0.55%
IJR iShares Core S&P Small-Cap ETF 0.43%

Comparables

Edit
VCEL Vericel Corp
IONS Ionis Pharmaceuticals Inc
UTHR United Therapeutics Corp
OMI Owens & Minor Inc
SAGE Sage Therapeutics Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.